Literature DB >> 19833395

Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia.

R Pul1, T Kopadze, T Skripuletz, E V Voss, B C Kieseier, M Stangel.   

Abstract

In multiple sclerosis (MS) matrix metalloproteinases (MMP) are believed to be involved in the disruption of the blood brain barrier and demyelination. MMP-9 is increased in the cerebrospinal fluid of MS patients and expressed in MS lesions, indicating an involvement in MS pathogenesis. It is known that activated microglia secrete MMP. Modulation of MMP may thus be of interest for treatment in particular since MMP knock-out mice are less susceptible to experimental allergic encephalomyelitis. In this study we show that intact polyclonal immunoglobulins for intravenous use (IVIg) lead to increased secretion of MMP-9 in unstimulated microglia whereas F(ab')(2) fragments or stimulation with lipopolysaccharide (LPS) had no effect on MMP production at all. We could not detect MMP-2, MMP-3, MMP-7, MMP-10, MMP-11, and MMP-12 by RT-PCR with and without stimulation with LPS. IVIg differentially modulate MMP-9 production in resting and activated microglia suggesting an activation-dependent immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833395     DOI: 10.1016/j.jneuroim.2009.09.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells.

Authors:  Ronglin Jiang; Liling Wei; Meifei Zhu; Jiannong Wu; Lingcong Wang
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

2.  Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.

Authors:  Johanna Magga; Lakshman Puli; Rea Pihlaja; Katja Kanninen; Suvi Neulamaa; Tarja Malm; Wolfgang Härtig; Jens Grosche; Gundars Goldsteins; Heikki Tanila; Jari Koistinaho; Milla Koistinaho
Journal:  J Neuroinflammation       Date:  2010-12-07       Impact factor: 8.322

3.  Dose-dependent inhibition of demyelination and microglia activation by IVIG.

Authors:  Meike Winter; Christine Baksmeier; Julia Steckel; Sumanta Barman; Manish Malviya; Melanie Harrer-Kuster; Hans-Peter Hartung; Norbert Goebels
Journal:  Ann Clin Transl Neurol       Date:  2016-09-23       Impact factor: 4.511

4.  Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.

Authors:  Christine Baksmeier; Pat Blundell; Julia Steckel; Verena Schultz; Quan Gu; Ana Da Silva Filipe; Alain Kohl; Chris Linnington; Dongli Lu; Anne Dell; Stuart Haslam; Jiabin Wang; Dan Czajkowsky; Norbert Goebels; Richard J Pleass
Journal:  Immunology       Date:  2021-05-09       Impact factor: 7.215

5.  Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia.

Authors:  Maike Gold; David Mengel; Stephan Röskam; Richard Dodel; Jan-Philipp Bach
Journal:  J Neuroinflammation       Date:  2013-01-14       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.